New approach to 'punishment and reward' method of AI training offers potential for aggressive cancers

byUniversity of SurreyCredit: Unsplash/CC0 Public DomainA new "outside-the-box" method of teaching artificial intelligence (AI) models to make decisions could provide hope for finding

Updated on: January 11,2024

New approach to 'punishment and reward' method of AI training offers potential for aggressive cancers

byUniversity of SurreyCredit: Unsplash/CC0 Public DomainA new "outside-the-box" method of teaching artificial intelligence (AI) models to make decisions could provide hope for finding

Updated on:January 11,2024

Research targets metformin as breast cancer prescription

by Louisiana State UniversityCredit: LSU HealthResearch conducted by Suresh Alahari, Ph.D., Professor of Biochemistry and Genetics at LSU Health New Orleans School of Medicine, has found that met

Updated on: July 02,2024

Research targets metformin as breast cancer prescription

by Louisiana State UniversityCredit: LSU HealthResearch conducted by Suresh Alahari, Ph.D., Professor of Biochemistry and Genetics at LSU Health New Orleans School of Medicine, has found that met

Updated on:July 02,2024

Researchers identify a subset of patients with early melanoma who face a very low risk of dying from the disease

by WileyMelanoma. Credit: Wikimedia Commons/National Cancer InstituteAlthough melanoma is the most serious type of skin cancer, most patients have high chances of surviving the disease. There is

Updated on: February 23,2024

Researchers identify a subset of patients with early melanoma who face a very low risk of dying from the disease

by WileyMelanoma. Credit: Wikimedia Commons/National Cancer InstituteAlthough melanoma is the most serious type of skin cancer, most patients have high chances of surviving the disease. There is

Updated on:February 23,2024

The right moves: How studying cell movement during embryonic development may offer new insights into cancer metastasis

by Ian Demsky,Memorial Sloan Kettering Cancer CenterUnder the microscope, MSK scientists studied how cells in a mouse embryo (green) move out and break away from their original tissue by contrac

Updated on: February 23,2024

The right moves: How studying cell movement during embryonic development may offer new insights into cancer metastasis

by Ian Demsky,Memorial Sloan Kettering Cancer CenterUnder the microscope, MSK scientists studied how cells in a mouse embryo (green) move out and break away from their original tissue by contrac

Updated on:February 23,2024

Predicting immunotherapy response and guiding combination therapy with MOTIF

byScience China PressWorkflow of MOTIF and three main application including cellular function analysis, immunotherapy response prediction and combinational therapy guidance. Credit: Science Chin

Updated on: March 30,2024

Predicting immunotherapy response and guiding combination therapy with MOTIF

byScience China PressWorkflow of MOTIF and three main application including cellular function analysis, immunotherapy response prediction and combinational therapy guidance. Credit: Science Chin

Updated on:March 30,2024

Telisotuzumab vedotin shows durable response in some Asian patients with nonsquamous NSCLC

by International Association for the Study of Lung CancerCredit: Pixabay/CC0 Public DomainThe c-Met-directed antibody-drug conjugate telisotuzumab vedotin demonstrated durable responses and an accepta

Updated on: September 27,2024

Telisotuzumab vedotin shows durable response in some Asian patients with nonsquamous NSCLC

by International Association for the Study of Lung CancerCredit: Pixabay/CC0 Public DomainThe c-Met-directed antibody-drug conjugate telisotuzumab vedotin demonstrated durable responses and an accepta

Updated on:September 27,2024

Adding pembrolizumab to chemo improves survival in cervical cancer, finds study

by Elana GotkineFor women with persistent, recurrent, or metastatic cervical cancer, adding pembrolizumab to chemotherapy, with or without bevacizumab, is associated with improved overall and progress

Updated on: January 23,2024

Adding pembrolizumab to chemo improves survival in cervical cancer, finds study

by Elana GotkineFor women with persistent, recurrent, or metastatic cervical cancer, adding pembrolizumab to chemotherapy, with or without bevacizumab, is associated with improved overall and progress

Updated on:January 23,2024

Researchers chart a course for understanding, preventing and treating young-onset colorectal cancer

by Dana-Farber Cancer InstituteCredit: Unsplash/CC0 Public DomainColorectal cancer among young people is increasing globally and rapidly. Experts expect it to become the leading cause of cancer d

Updated on: February 18,2024

Researchers chart a course for understanding, preventing and treating young-onset colorectal cancer

by Dana-Farber Cancer InstituteCredit: Unsplash/CC0 Public DomainColorectal cancer among young people is increasing globally and rapidly. Experts expect it to become the leading cause of cancer d

Updated on:February 18,2024

Tumor macrophage marker offers unique target for treatment

by National Institutes of HealthA nanoparticle attached to CRV (CRV-NP) specifically homed to macrophages in breast tumors in mice (yellow arrow) and did not home to spleen, lung or heart. Nanopa

Updated on: April 09,2024

Tumor macrophage marker offers unique target for treatment

by National Institutes of HealthA nanoparticle attached to CRV (CRV-NP) specifically homed to macrophages in breast tumors in mice (yellow arrow) and did not home to spleen, lung or heart. Nanopa

Updated on:April 09,2024

Study finds large gap in breast cancer treatment recommendations for patients aged 70 vs. 69

byAmerican Society for Radiation OncologyCredit: Unsplash/CC0 Public DomainAge-based heuristics can lead to large differences in breast cancer treatment based on small differences in chronologic

Updated on: January 23,2024

Study finds large gap in breast cancer treatment recommendations for patients aged 70 vs. 69

byAmerican Society for Radiation OncologyCredit: Unsplash/CC0 Public DomainAge-based heuristics can lead to large differences in breast cancer treatment based on small differences in chronologic

Updated on:January 23,2024

A smart watch for lymphoedema management

by Astrid Tomczak,ETH ZurichThe Dicronis entrepreneurs Laura Jabinet, Jovan Jancev and Patrizia Marschalkova (from left). Credit: ETH Zürich / Florian BachmannAbout ten percent of all cancer pat

Updated on: May 09,2024

A smart watch for lymphoedema management

by Astrid Tomczak,ETH ZurichThe Dicronis entrepreneurs Laura Jabinet, Jovan Jancev and Patrizia Marschalkova (from left). Credit: ETH Zürich / Florian BachmannAbout ten percent of all cancer pat

Updated on:May 09,2024

Study results show conjugate therapy produced remissions in one-third of patients with drug-resistant ovarian cancer

by Dana-Farber Cancer InstituteAntitumor activity of mirvetuximab soravtansine. (A) Maximum percentage change in target lesion size from baseline. Best response according to RECIST is indicated b

Updated on: January 30,2024

Study results show conjugate therapy produced remissions in one-third of patients with drug-resistant ovarian cancer

by Dana-Farber Cancer InstituteAntitumor activity of mirvetuximab soravtansine. (A) Maximum percentage change in target lesion size from baseline. Best response according to RECIST is indicated b

Updated on:January 30,2024